137 related articles for article (PubMed ID: 31859554)
1. DECREASE IN ACROMEGALY-ASSOCIATED THYROID ENLARGEMENT AFTER NORMALIZATION OF IGF-1 LEVELS: A PROSPECTIVE OBSERVATION AND IN VITRO STUDY.
Chen Z; Jiang X; Feng Y; Li X; Chen D; Mao Z; He D; Zhu Y; Wang H
Endocr Pract; 2020 Apr; 26(4):369-377. PubMed ID: 31859554
[No Abstract] [Full Text] [Related]
2. Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up.
Cannavò S; Squadrito S; Finocchiaro MD; Curtò L; Almoto B; Vieni A; Trimarchi F
Horm Metab Res; 2000 May; 32(5):190-5. PubMed ID: 10871160
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.
Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A;
J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466
[TBL] [Abstract][Full Text] [Related]
4. The effect of acromegaly on thyroid disease.
Mo C; Zhong L
Endocr J; 2023 Nov; 70(11):1051-1060. PubMed ID: 37880078
[TBL] [Abstract][Full Text] [Related]
5. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
6. Thyroid vascularity is increased in patients with active acromegaly.
Bogazzi F; Manetti L; Bartalena L; Gasperi M; Grasso L; Cecconi E; Rago T; Pinchera A; Martino E
Clin Endocrinol (Oxf); 2002 Jul; 57(1):65-70. PubMed ID: 12100071
[TBL] [Abstract][Full Text] [Related]
7. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
[TBL] [Abstract][Full Text] [Related]
8. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels.
Miyakawa M; Saji M; Tsushima T; Wakai K; Shizume K
J Clin Endocrinol Metab; 1988 Nov; 67(5):973-8. PubMed ID: 3053751
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
10. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
11. Central Hypothyroidism Related to Pituitary Adenomas: Low Incidence of Central Hypothyroidism in Patients With Acromegaly.
Takamizawa T; Horiguchi K; Nakajima Y; Okamura T; Ishida E; Matsumoto S; Yoshino S; Yamada E; Saitoh T; Ozawa A; Tosaka M; Yamada S; Yamada M
J Clin Endocrinol Metab; 2019 Oct; 104(10):4879-4888. PubMed ID: 31188431
[TBL] [Abstract][Full Text] [Related]
12. Effects of growth hormone on thyroid function are mediated by type 2 iodothyronine deiodinase in humans.
Yamauchi I; Sakane Y; Yamashita T; Hirota K; Ueda Y; Kanai Y; Yamashita Y; Kondo E; Fujii T; Taura D; Sone M; Yasoda A; Inagaki N
Endocrine; 2018 Feb; 59(2):353-363. PubMed ID: 29274063
[TBL] [Abstract][Full Text] [Related]
13. The Effect and Potential Mechanism Analysis of Growth Hormone-Secreting Pituitary Adenomas on Thyroid Function.
Mo C; Chen H; Guo Y; Li Z; Wang Y; Zhong L
Endocr Pract; 2023 Jul; 29(7):546-552. PubMed ID: 37217118
[TBL] [Abstract][Full Text] [Related]
14. Thyroid gland changes in patients with acromegaly.
Natchev E; Vandeva S; Kovatcheva R; Kirilov G; Kalinov K; Zacharieva S
Arch Endocrinol Metab; 2020; 64(3):269-275. PubMed ID: 32555993
[TBL] [Abstract][Full Text] [Related]
15. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
16. The thyroid gland in acromegaly: an ultrasonographic study.
Cheung NW; Boyages SC
Clin Endocrinol (Oxf); 1997 May; 46(5):545-9. PubMed ID: 9231049
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of slow-release lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma.
Cannavò S; Squadrito S; Curtò L; Almoto B; Trimarchi F
Horm Metab Res; 2001 Oct; 33(10):618-24. PubMed ID: 11607883
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
[TBL] [Abstract][Full Text] [Related]
19. Lacrimal gland enlargement and tear film changes in acromegaly patients: A controlled study.
Mergen B; Arici C; Kizilkilic O; Tanriover N; Kadioglu P
Growth Horm IGF Res; 2021 Aug; 59():101397. PubMed ID: 34023594
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
